Locally Advanced NSCLC Hyperfractionated RT

NCT03128008 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non Small Cell Lung (NSCLC)

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
RADIATION: Daily hyperfractionated radiation therapy

Sponsor

Duke University